SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-15-149596
Filing Date
2015-04-27
Accepted
2015-04-27 16:31:41
Documents
3
Period of Report
2015-06-09
Effectiveness Date
2015-04-27

Document Format Files

Seq Description Document Type Size
1 DEF 14A d897986ddef14a.htm DEF 14A 322481
2 GRAPHIC g897986g57i48.jpg GRAPHIC 22171
3 GRAPHIC g897986g83n03.jpg GRAPHIC 27118
  Complete submission text file 0001193125-15-149596.txt   391947
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36332 | Film No.: 15795515
SIC: 2834 Pharmaceutical Preparations